{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:27:34Z","timestamp":1785799654023,"version":"3.56.0"},"update-to":[{"DOI":"10.1016\/j.biopha.2021.112162","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000}}],"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002836","name":"Chang Gung University","doi-asserted-by":"publisher","award":["SCRPD1L0221"],"award-info":[{"award-number":["SCRPD1L0221"]}],"id":[{"id":"10.13039\/501100002836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.biopha.2021.112162","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T01:44:56Z","timestamp":1631151896000},"page":"112162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["RETRACTED: Nanoparticles as an effective drug delivery system in COVID-19"],"prefix":"10.1016","volume":"143","author":[{"given":"Neehasri Kumar","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Deepika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshma","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav Ambadas","family":"Sonawane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar","family":"Mavinamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramendra Pati","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Ming","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.112162_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijsu.2020.05.018","article-title":"Diagnosis and treatment of coronavirus disease 2019 (COVID-19): laboratory, PCR, and chest CT imaging findings","volume":"79","author":"Abbasi-Oshaghi","year":"2020","journal-title":"Int J. Surg."},{"issue":"2","key":"10.1016\/j.biopha.2021.112162_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00221-18","article-title":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease","volume":"9","author":"Agostini","year":"2018","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.biopha.2021.112162_bib3","article-title":"COVID-19 & effectiveness towards it\u2019s available treatment","volume":"7","author":"Bablani","year":"2020","journal-title":"IJRAR Int. J. Res. Anal. Rev. IJRAR"},{"issue":"1","key":"10.1016\/j.biopha.2021.112162_bib4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/med.20140","article-title":"Nanoparticle formulations in pulmonary drug delivery","volume":"29","author":"Bailey","year":"2009","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.biopha.2021.112162_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.matlet.2017.07.072","article-title":"Drug delivery and cytocompatibility of ciprofloxacin loaded gelatin nanofibers-coated Mg alloy","volume":"207","author":"Bakhsheshi-Rad","year":"2017","journal-title":"Mater. Lett."},{"issue":"2","key":"10.1016\/j.biopha.2021.112162_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12016-010-8243-x","article-title":"Hydroxychloroquine: from malaria to autoimmunity","volume":"42","author":"Ben-Zvi","year":"2012","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.biopha.2021.112162_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.colsurfa.2017.07.026","article-title":"Influence of crosslinked alginate on drug release from highly concentrated emulsions","volume":"536","author":"Bonilla","year":"2018","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.biopha.2021.112162_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104541","article-title":"Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase","volume":"169","author":"Brown","year":"2019","journal-title":"Antivir. Res."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.112162_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijpharm.2017.05.005","article-title":"Microemulsion utility in pharmaceuticals: implications for multi-drug delivery","volume":"526","author":"Callender","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2021.112162_bib10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41422-020-0327-4","article-title":"COVID-19: towards understanding of pathogenesis","volume":"30","author":"Cao","year":"2020","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.112162_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcv.2004.03.003","article-title":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds","volume":"31","author":"Chen","year":"2004","journal-title":"J. Clin. Virol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112162_bib12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"issue":"10.1016","key":"10.1016\/j.biopha.2021.112162_bib13","article-title":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19","volume":"55","author":"Colson","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.biopha.2021.112162_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jcrc.2020.03.005","article-title":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19","volume":"57","author":"Cortegiani","year":"2020","journal-title":"J. Crit. Care"},{"issue":"3","key":"10.1016\/j.biopha.2021.112162_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"issue":"12","key":"10.1016\/j.biopha.2021.112162_bib16","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","volume":"117","author":"de Wit","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.112162_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1773-2247(07)50007-9","article-title":"Evaluation of the physicochemical characteristics and activity of various kinds of ciprofloxacin HCl-loaded cationic nanoparticles","volume":"17","author":"Dillen","year":"2007","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biopha.2021.112162_bib18","series-title":"Recent Advances in Biopolymers","first-page":"19","article-title":"Biopolymer-mediated green synthesis of noble metal nanostructures","author":"Fakayode","year":"2016"},{"key":"10.1016\/j.biopha.2021.112162_bib19","series-title":"Coronaviruses","first-page":"1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","author":"Fehr","year":"2015"},{"issue":"1_suppl","key":"10.1016\/j.biopha.2021.112162_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0961203396005001031","article-title":"Anti-malarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development","volume":"5","author":"Fox","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.biopha.2021.112162_bib21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0049-0172(10)80012-5","article-title":"Mechanism of action of hydroxychloroquine as an antirheumatic drug","volume":"23","author":"Fox","year":"1993","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.biopha.2021.112162_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.msec.2017.12.028","article-title":"Curcumin nanocapsules stabilized by bovine serum albumin-capped gold nanoclusters (BSA-AuNCs) for drug delivery and theranosis","volume":"87","author":"Fu","year":"2018","journal-title":"Mater. Sci. Eng.: C."},{"issue":"15","key":"10.1016\/j.biopha.2021.112162_bib23","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1074\/jbc.AC120.013056","article-title":"The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"33","key":"10.1016\/j.biopha.2021.112162_bib24","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1073\/pnas.0801763105","article-title":"The effect of particle design on cellular internalization pathways","volume":"105","author":"Gratton","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5153","key":"10.1016\/j.biopha.2021.112162_bib25","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1126\/science.8128245","article-title":"Biodegradable long-circulating polymeric nanospheres","volume":"263","author":"Gref","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.biopha.2021.112162_bib26","article-title":"A review of COVID-19 (Coronavirus disease-2019) Diagnosis","author":"Hafeez","year":"2019","journal-title":"Treat. Prev."},{"key":"10.1016\/j.biopha.2021.112162_bib27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.colsurfa.2017.08.028","article-title":"CO2 bubble assisted layer-by-layer self-assembly of graphene oxide multilayer film","volume":"533","author":"Heo","year":"2017","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.biopha.2021.112162_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejpb.2018.01.016","article-title":"Inflamed site-specific drug delivery system based on the interaction of human serum albumin nanoparticles with myeloperoxidase in a murine model of experimental colitis","volume":"125","author":"Iwao","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2021.112162_bib29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ijbiomac.2016.05.032","article-title":"A simple improved desolvation method for the rapid preparation of albumin nanoparticles","volume":"91","author":"Jahanban-Esfahlan","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2021.112162_bib30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.powtec.2017.02.021","article-title":"Chitosan-based spray-dried mucoadhesive microspheres for sustained oromucosal drug delivery","volume":"312","author":"Jiang","year":"2017","journal-title":"Powder Technol."},{"key":"10.1016\/j.biopha.2021.112162_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105933","article-title":"Arguments in favour of remdesivir for treating SARS-CoV-2 infections","volume":"55","author":"Ko","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.biopha.2021.112162_bib32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.carbpol.2017.08.010","article-title":"Collagen and hyaluronic acid hydrogel in water-in-oil microemulsion delivery systems","volume":"175","author":"Kupper","year":"2017","journal-title":"Carbohydr. Polym."},{"issue":"2","key":"10.1016\/j.biopha.2021.112162_bib33","first-page":"163","article-title":"Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery","volume":"13","author":"Liang","year":"2018","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2021.112162_bib34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-chembioeng-073009-100847","article-title":"Polymers for drug delivery systems","volume":"1","author":"Liechty","year":"2010","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"issue":"6","key":"10.1016\/j.biopha.2021.112162_bib35","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00006565-200012000-00003","article-title":"Acetaminophen and ibuprofen dosing by parents","volume":"16","author":"Li","year":"2000","journal-title":"Pediatr. Emerg. Care"},{"key":"10.1016\/j.biopha.2021.112162_bib36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.biomaterials.2017.03.001","article-title":"A VEGF delivery system targeting MI improves angiogenesis and cardiac function based on the tropism of MSCs and layer-by-layer self-assembly","volume":"127","author":"Liu","year":"2017","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.biopha.2021.112162_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jgg.2020.02.001","article-title":"Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines","volume":"47","author":"Liu","year":"2020","journal-title":"J. Genet. Genom.\u00a0Yi Chuan Xue Bao"},{"issue":"2","key":"10.1016\/j.biopha.2021.112162_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/pi.4822","article-title":"Preparation of polymeric nanoparticles by novel electrospray nanoprecipitation","volume":"64","author":"Luo","year":"2015","journal-title":"Polym. Int."},{"issue":"10229","key":"10.1016\/j.biopha.2021.112162_bib39","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.biopha.2021.112162_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/pharmaceutics9040053","article-title":"An overview of chitosan nanoparticles and its application in non-parenteral drug delivery","volume":"9","author":"Mohammed","year":"2017","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2021.112162_bib41","first-page":"47","article-title":"Biopolymers\u2013application in nanoscience and nanotechnology","volume":"1","author":"Mohan","year":"2016","journal-title":"Recent Adv. Biopolym."},{"key":"10.1016\/j.biopha.2021.112162_bib42","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.carbpol.2018.02.062","article-title":"Development of electrosprayed mucoadhesive chitosan microparticles","volume":"190","author":"Moreno","year":"2018","journal-title":"Carbohydr. Polym."},{"issue":"11","key":"10.1016\/j.biopha.2021.112162_bib43","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1248\/cpb.58.1423","article-title":"Chitosan nanoparticles: a promising system in novel drug delivery","volume":"58","author":"Nagpal","year":"2010","journal-title":"Chem. Pharm. Bull."},{"issue":"5","key":"10.1016\/j.biopha.2021.112162_bib44","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1128\/JVI.02322-09","article-title":"Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae","volume":"84","author":"O\u2019Keefe","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2021.112162_bib45","unstructured":"Organization, W.H. (2020). Population-based age-stratified seroepidemiological investigation protocol for coronavirus 2019 (COVID-19) infection, 26 May 2020. Retrieved from."},{"issue":"8","key":"10.1016\/j.biopha.2021.112162_bib46","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles for therapeutic applications","volume":"9","author":"Petros","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2021.112162_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.crgsc.2020.100011","article-title":"Tackling COVID-19 pandemic through nanocoatings: confront and exactitude","volume":"3","author":"Rai","year":"2020","journal-title":"Curr. Res. Green. Sustain. Chem."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.112162_bib48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijpharm.2013.07.034","article-title":"Chitosan nanoparticles: preparation, size evolution and stability","volume":"455","author":"Rampino","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2021.112162_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","volume":"109","author":"Rothan","year":"2020","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.biopha.2021.112162_bib50","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S2213-2600(13)70072-9","article-title":"Pulmonary drug delivery: from generating aerosols to overcoming biological barriers\u2014therapeutic possibilities and technological challenges","volume":"1","author":"Ruge","year":"2013","journal-title":"Lancet Respir. Med."},{"issue":"6","key":"10.1016\/j.biopha.2021.112162_bib51","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1517\/17425247.5.6.629","article-title":"Biodegradable polymeric nanocarriers for pulmonary drug delivery","volume":"5","author":"Rytting","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"issue":"5","key":"10.1016\/j.biopha.2021.112162_bib52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1371\/journal.pmed.0020097","article-title":"Nanotechnology and the developing world","volume":"2","author":"Salamanca-Buentello","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.biopha.2021.112162_bib53","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.eurpolymj.2017.12.024","article-title":"Hybrid gelatin-based porous materials with a tunable multiscale morphology for tissue engineering and drug delivery","volume":"99","author":"Salerno","year":"2018","journal-title":"Eur. Polym. J."},{"issue":"2","key":"10.1016\/j.biopha.2021.112162_bib54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1473-3099(06)70361-9","article-title":"New insights into the antiviral effects of chloroquine","volume":"6","author":"Savarino","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.biopha.2021.112162_bib55","article-title":"Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts\u2019 consensus statement [published online February 7, 2020]","author":"Shen","year":"2019","journal-title":"World J. Pedia"},{"key":"10.1016\/j.biopha.2021.112162_bib56","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.biopha.2021.112162_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107512","article-title":"Favipiravir, an anti-influenza drug against life-threatening RNA virus infections","volume":"209","author":"Shiraki","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2021.112162_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.snb.2016.12.120","article-title":"A nanostructured cell-free photosynthetic biocomposite via molecularly controlled layer-by-layer assembly","volume":"244","author":"Shon","year":"2017","journal-title":"Sens. Actuators B: Chem."},{"key":"10.1016\/j.biopha.2021.112162_bib59","series-title":"Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo [2, 1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses","author":"Siegel","year":"2017"},{"issue":"5","key":"10.1016\/j.biopha.2021.112162_bib60","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3390\/nano10050852","article-title":"On facing the SARS-CoV-2 (COVID-19) with combination of nanomaterials and medicine: possible strategies and first challenges","volume":"10","author":"Sivasankarapillai","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biopha.2021.112162_bib61","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.carbpol.2017.08.045","article-title":"Microparticle-embedded fibroin\/alginate beads for prolonged local release of simvastatin hydroxyacid to mesenchymal stem cells","volume":"175","author":"Ungaro","year":"2017","journal-title":"Carbohydr. Polym."},{"issue":"2","key":"10.1016\/j.biopha.2021.112162_bib62","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/02652048.2011.635218","article-title":"Albumin nanoparticles with predictable size by desolvation procedure","volume":"29","author":"Von Storp","year":"2012","journal-title":"J. Microencapsul."},{"issue":"3","key":"10.1016\/j.biopha.2021.112162_bib63","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2021.112162_bib64","unstructured":"A. Waris, M. Ali, A.U. Khan, A. Ali, A. Baset, Role of nanotechnology in diagnosing and treating COVID-19 during the Pandemic."},{"issue":"7594","key":"10.1016\/j.biopha.2021.112162_bib65","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"issue":"7809","key":"10.1016\/j.biopha.2021.112162_bib66","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"W\u00f6lfel","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2021.112162_bib67","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.matlet.2015.12.151","article-title":"Development of silk fibroin-derived nanofibrous drug delivery system in supercritical CO2","volume":"167","author":"Xie","year":"2016","journal-title":"Mater. Lett."},{"key":"10.1016\/j.biopha.2021.112162_bib68","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.actbio.2016.10.026","article-title":"Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis","volume":"48","author":"Xu","year":"2017","journal-title":"Acta Biomater."},{"issue":"6","key":"10.1016\/j.biopha.2021.112162_bib69","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jmv.25729","article-title":"A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus\u2014a possible reference for coronavirus disease\u201019 treatment option","volume":"92","author":"Yao","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.biopha.2021.112162_bib70","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"71","author":"Yao","year":"2020","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"issue":"7","key":"10.1016\/j.biopha.2021.112162_bib71","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1023\/A:1018908421434","article-title":"Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release","volume":"16","author":"Yoo","year":"1999","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.112162_bib72","first-page":"25","article-title":"Engineering biodegradable nanoparticles for drug and gene delivery","volume":"109","author":"Zhang","year":"2013","journal-title":"Chem. Eng. Prog."},{"issue":"10","key":"10.1016\/j.biopha.2021.112162_bib73","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.7150\/ijbs.45053","article-title":"SARS-CoV-2: an emerging coronavirus that causes a global threat","volume":"16","author":"Zheng","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2021.112162_fur1","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/cid\/ciz544","article-title":"Ribavirin and interferon therapy for critically ill patients with middle east respiratory syndrome: a multicenter observational study","volume":"70","author":"Arabi","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2021.112162_fur2","series-title":"Strategies to Modify the Drug Release from Pharmaceutical Systems","author":"Bruschi","year":"2015"},{"issue":"5","key":"10.1016\/j.biopha.2021.112162_fur3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/17425255.2019.1604685","article-title":"Pharmacokinetics and pharmacodynamics of cytochrome P450 inhibitors for HIV treatment","volume":"15","author":"Gong","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"13","key":"10.1016\/j.biopha.2021.112162_fur4","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.7150\/thno.46691","article-title":"Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients","volume":"10","author":"Itani","year":"2020","journal-title":"Theranostics"},{"issue":"6\u20137","key":"10.1016\/j.biopha.2021.112162_fur5","first-page":"385","article-title":"General and cardiac toxicity of doxorubicin-loaded gelatin nanoparticles","volume":"52","author":"Leo","year":"1997","journal-title":"Farm. (Soc. Chim. Ital.: 1989)"},{"issue":"3","key":"10.1016\/j.biopha.2021.112162_fur6","first-page":"7423","article-title":"Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2): an update","volume":"12","author":"Pal","year":"2020","journal-title":"Cureus"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.112162_fur7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijpharm.2017.02.005","article-title":"Stem cell-extracellular vesicles as drug delivery systems: New frontiers for silk\/curcumin nanoparticles","volume":"520","author":"Perteghella","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2021.112162_fur8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijpharm.2017.11.050","article-title":"Active freeze drying for production of nanocrystal-based powder: a pilot study","volume":"536","author":"Touzet","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2021.112162_fur9","series-title":"Biomaterials","first-page":"59","article-title":"Chitosan: a versatile biomaterial.","author":"Yilmaz","year":"2004"},{"issue":"17","key":"10.1016\/j.biopha.2021.112162_fur10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.112162_fur11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41256-020-00135-6","article-title":"The novel coronavirus outbreak in Wuhan, China","volume":"5","author":"Zhu","year":"2020","journal-title":"Glob. Health Res Policy"},{"issue":"9393","key":"10.1016\/j.biopha.2021.112162_fur12","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(03)14630-2","article-title":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People\u2019s Republic of China, in February, 2003","volume":"362","author":"Zhong","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2021.112162_fur13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2217\/nnm-2020-0441","article-title":"Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives","volume":"16.6","author":"Rashidzadeh","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2021.112162_fur14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/microorganisms9020232","article-title":"A comprehensive review of detection methods for SARS-CoV-2","volume":"9","author":"Eftekhari","year":"2021","journal-title":"Microorganisms"}],"updated-by":[{"DOI":"10.1016\/j.biopha.2026.119150","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000}},{"DOI":"10.1016\/j.biopha.2021.112162","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000}},{"DOI":"10.1016\/j.biopha.2026.119150","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100946X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100946X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T02:47:01Z","timestamp":1774666021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222100946X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":87,"alternative-id":["S075333222100946X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112162","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Nanoparticles as an effective drug delivery system in COVID-19","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112162"}}